Together, these data established a Wnt/beta-catenin - collagen axis in breast cancer cells, and demonstrated that Wnt/beta-catenin pathway inhibition by either IWR-1 or CS-E interferes with Wnt3a-mediated induction of Col1a1 expression. The gene discussed is WNT3A; the disease is breast carcinoma.